Clinical Trial Update: VAC Regimen for AML Patients Who Failed to Response to VA Regimen [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 VAC regimen in AML patients who did not respond to VA regimen; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• VAC regimen

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING